HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Utah Silver Supplement Provider's COVID-19 Remedy Claim No Surprise To Authorities

Executive Summary

Federal court issues TRO blocking My Doctor Suggests, GP Silver and their  owner, Gordon Pedersen, from continuing to sell or distribute silver colloidal products for the diagnosis, cure, mitigation, treatment or prevention of any disease.

You may also be interested in...



Consumer Health Fraud: Collidial Silver A Pandemic Repeat Offender

COVID-19 makes silver a gift that keeps on giving for US regulators with another business closed by court order; Seattle area naturopath charged with selling misbranded drug as a virus prevention; FTC reaches settlements with operators of “free trial” schemes for cosmetics and supplements; FDA announces criminal convictions of two men who defrauded the agency by misbranding steroid drugs they sold OTC.

On Pandemic Alert, Regulators See ‘Yellow Flags’ In Immunity Claims For Supplements

Supplement immunity claims are more likely to get regulators’ attention when they also explain immunity’s importance, often moving into treatment claims, says attorney Justin Prochnow. Hash tags mentioning COVID-19 or staying healthy during the pandemic also can suggest products treat the virus.

Licorice Root, ‘Cough Syrup’ And Nasal Spray Among Bogus COVID-19 Remedies In US

All the online retailers FDA and FTC most recently warned appear to have removed false claims as of 13 May. A rural lifestyle outfitter among the warned businesses, however, touted its licorice root remedy on social media after receiving a warning.

Related Content

Topics

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel